The Use of the Title “Dr.”: Professional Identity, Patient Clarity and Regulatory Responsibility

Titles carry weight. In professional settings, they communicate training, scope of practice, professional identity, and a person’s role in society. Of all professional titles, “Doctor” is among the most respected, but also among the most easily misunderstood.

This is especially important in healthcare, where how a professional introduces themselves can directly affect patient understanding, safety, confidence, and trust.

1. The Origin and Two Meanings of “Doctor”

The word “doctor” comes from the Latin docere, meaning “to teach.” Historically, it was an academic title awarded to individuals who had attained the highest level of education in a particular field.

In modern healthcare, however, society also associates “doctor” with a specific clinical role: the medical practitioner licensed to diagnose disease, prescribe treatment, and take overall responsibility for medical care.

This dual meaning is where confusion begins. An academic or professional doctorate and a medical qualification may both represent years of rigorous study, but public expectations of the title “Doctor” differ significantly in a hospital, clinic, community pharmacy, classroom, or research setting.

2. The Case of the Doctor of Pharmacy in Ghana

In Ghana, professionals now graduate with the PharmD, the Doctor of Pharmacy degree. This six-year professional doctorate includes training in pharmacology, therapeutics, clinical pharmacy, pharmaceutical care, and patient-centred practice. It is a significant academic and professional achievement that deserves recognition.

The emergence of the PharmD gives Ghana an important opportunity to reconcile two legitimate interests: recognizing the Doctor of Pharmacy as a professional doctorate, while protecting patients from ambiguity about professional roles.

To many Ghanaian patients, the title “Doctor” usually means a medical doctor, that is, the person trained in full-body pathology and differential diagnosis, licensed to diagnose illness, prescribe treatment, and bear ultimate legal and clinical responsibility where a diagnosis is missed, or care is mismanaged.

Where professional identity is not made explicit, the use of an undifferentiated doctoral title may create uncertainty about the practitioner’s role, with implications for informed communication and patient understanding.

When a PharmD holder introduces themselves simply as “Doctor A” or “Doctor B” in a hospital, clinic, or community pharmacy, the title may be technically defensible but practically ambiguous. It may lead patients to assume they are speaking to a medical doctor rather than a pharmacist with doctoral-level training. This is not merely a semantic concern. It can result in:

1. Patient safety risks: Patients may make health decisions based on a mistaken understanding of the professional role of the person advising them.
2. Role confusion: Healthcare is team-based. Medical doctors, pharmacists, nurses, physician assistants, laboratory professionals, and other practitioners all perform distinct and essential functions. When titles blur, responsibilities may also become unclear.
3. Erosion of public trust: When patients later feel misled, even unintentionally, trust in individual professionals and the wider health system may weaken.

When you introduce yourself as "Doctor," patients assume you are a medical doctor, meaning any life-saving catch or expert advice you provide is credited to the medical profession rather than the pharmacy profession.

International practice reflects this concern for clarity. In countries such as the United States, the United Kingdom, and Canada, PharmD holders may use the title “Doctor” in academic and professional contexts, but in clinical settings they are generally expected to make their professional role clear. A transparent introduction such as “I am Dr. Apuskeleke, your pharmacist” recognizes the doctorate while ensuring that patients understand the practitioner’s role.

3. The Principle of Non-Misleading Representation

Professional ethics across health disciplines emphasize honesty, transparency, and respect for the public. A central principle is that no health professional should represent themselves in a way that may mislead patients about their qualifications, licence, scope of practice, or clinical role. This principle does not diminish academic achievement. Rather, it protects the public by ensuring that titles used in service delivery are accompanied by clear professional identification.

The issue, therefore, is not whether a pharmacist who has earned a PharmD deserves recognition. The issue is whether using the title “Doctor” in patient-facing settings should be accompanied by explicit identification of the practitioner as a pharmacist.

4. The Role of the Regulator: The Pharmacy Council Must Provide Guidance

While individual professionals have a duty to communicate clearly, the regulator has an even greater responsibility to set standards that protect the public and guide the profession.

The Pharmacy Council of Ghana, as the body mandated to regulate pharmacy education, practice, professional conduct, and standards, should provide clear guidance on how PharmD holders may use the title “Doctor” in different settings. Silence from the regulator risks allowing inconsistent practice, public misunderstanding, and unnecessary tension between professional groups. Clear guidelines would protect patients, protect pharmacists, protect interprofessional collaboration, and preserve the integrity of the PharmD qualification.

The Pharmacy Council should consider the following actions:

The Code of Ethics should clearly state how pharmacists with doctoral qualifications may use the title in academic, professional, clinical, and public-facing settings. Acceptable forms may include “Dr. A, Pharmacist,” “Dr. A, Doctor of Pharmacy,” “Dr. A, PharmD,” “Pharm Dr. A,” or “Dr. A (Pharm),” provided the professional role is clear to the public.

The Council should also make it clear that willful misrepresentation, or any form of title usage intended or likely to mislead patients into believing that a pharmacist is a medical doctor, is professionally unacceptable.

The Pharmacy Council should work with the Ghana Medical Association, Ghana Health Service, teaching institutions, professional pharmacy bodies, health facility managers, and patient representatives to develop a national standard that is practical, respectful, and consistent across health facilities. Such engagement is essential because title usage affects not only pharmacists, but the wider healthcare team and the patients they serve.

Regulation is not about diminishing anyone’s achievement. It is about clarity, accountability, and patient protection. When patients walk into a health facility, they deserve to know exactly who is attending to them and what that professional is qualified and licensed to do.

Conclusion

In patient care and public-facing settings, the title should be accompanied by clear professional identification. Introductions such as “I am Dr. ABC, your pharmacist,” “I am Dr. A, Doctor of Pharmacy,” or “I am your pharmacist” provide the clarity patients need. This approach protects patients, respects distinct scopes of practice within healthcare, strengthens interprofessional trust, and upholds the value and integrity of the PharmD degree.

In healthcare, clear communication is not a courtesy; it is a patient-safety obligation. Ghanaian PharmD holders have earned the right to be recognized for their doctoral qualification. Using the full professional identity in public and patient-facing settings is not a demotion. It is a mark of professionalism, honesty, and respect for the patient.

This discussion is not an argument against the use of the title “Dr.” by pharmacists who have legitimately earned a recognized doctoral qualification. Nor does it question the academic or professional status of the PharmD. Rather, it argues that doctoral recognition and professional identification should operate together.

The question before Ghana is therefore not whether a pharmacist who has earned a PharmD should be called “Dr.” The more important question is whether patients should ever have to guess what kind of professional is standing before them.

Professions don’t die because people stop needing them. They die because people stop understanding them! When we erase “Pharmacist” from how we introduce ourselves, we erase the profession from the public mind! Amicus Humani Generis!!!

Prof. Victor Wutor
Faculty of Public Health, Ghana College of Pharmacists

   Comments1